DEFA14A: Agilon Health Files Supplement to Correct Executive Compensation and Ownership Details
Supplement to Definitive Proxy Statement
Agilon Health files a supplement to its definitive proxy statement to correct information regarding executive compensation, beneficial ownership, and proxy solicitation.
Summary
- Agilon Health filed a supplement to its original proxy statement to correct certain information.
- The corrected information includes the percentage of votes cast in favor of the advisory vote on executive compensation at the 2024 annual meeting, which was approximately 82.8%.
- Jeffrey Schwaneke's final payout under the 2024 annual incentive program was correctly reported as $117,828, pro-rated for his employment period.
- Capital World Investors beneficially owns 48,368,009 shares, representing approximately 11.7% of the company's common stock as of September 30, 2024.
- The company retained Saratoga Proxy Consulting LLC on May 1, 2025, to assist in proxy solicitation for a fee of $12,500 plus expenses.
Sentiment
Score: 7
Explanation: The document is a routine correction of previously filed information. It doesn't contain any major positive or negative news, but ensures transparency, which is generally viewed favorably.
Positives
- The document provides corrected information to ensure transparency and accuracy for shareholders.
Future Outlook
The document does not contain any specific forward-looking statements beyond the upcoming annual meeting.
Industry Context
This filing is a routine update to a proxy statement, ensuring compliance with SEC regulations and providing accurate information to shareholders before the annual meeting. It's standard practice for publicly traded companies.
Stakeholder Impact
- Shareholders receive corrected information for informed voting decisions.
- Employees, particularly executives, are impacted by the corrected compensation details.
Next Steps
- Shareholders will likely review the corrected information before the upcoming annual meeting.
- The company will proceed with proxy solicitation with the assistance of Saratoga Proxy Consulting LLC.
Key Dates
| Date | Description |
|---|---|
| May 29, 2024 | Date of the Company's 2024 Annual Meeting of Stockholders. |
| September 30, 2024 | Date for beneficial ownership of Capital World Investors. |
| November 13, 2024 | Date of Amendment No. 4 to the Schedule 13G filed by Capital World Investors. |
| April 17, 2025 | Date of the Original Proxy Statement filing. |
| May 1, 2025 | Date the Company retained Saratoga Proxy Consulting LLC. |
Keywords
proxy statement, executive compensation, beneficial ownership, proxy solicitation, agilon health, shareholders
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.